PortfoliosLab logoPortfoliosLab logo
ALZN vs. MLGO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALZN vs. MLGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alzamend Neuro, Inc. (ALZN) and MicroAlgo Inc. (MLGO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALZN achieves a -36.81% return, which is significantly lower than MLGO's 15.61% return.


ALZN

1D
0.88%
1M
3.60%
YTD
-36.81%
6M
-44.17%
1Y
-69.97%
3Y*
-89.47%
5Y*
10Y*

MLGO

1D
-14.98%
1M
28.39%
YTD
15.61%
6M
-20.40%
1Y
-86.69%
3Y*
-92.78%
5Y*
-84.63%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALZN vs. MLGO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ALZN
Alzamend Neuro, Inc.
-36.81%-82.57%-86.97%-89.50%-70.27%-85.93%
MLGO
MicroAlgo Inc.
15.61%-96.08%-97.94%-27.04%-87.60%1.31%

Correlation

The correlation between ALZN and MLGO is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.31

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2021

0.13

The correlation between ALZN and MLGO shifts across timeframes, from 0.12 (3 years) to 0.31 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

EPS

ALZN:

-$2.27

MLGO:

$2.45

Total Revenue (TTM)

ALZN:

$0.00

MLGO:

$61.17M

Gross Profit (TTM)

ALZN:

-$68.06K

MLGO:

$16.42M

EBITDA (TTM)

ALZN:

-$6.97M

MLGO:

$3.58M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALZN vs. MLGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALZN
ALZN Risk / Return Rank: 66
Overall Rank
ALZN Sharpe Ratio Rank: 66
Sharpe Ratio Rank
ALZN Sortino Ratio Rank: 55
Sortino Ratio Rank
ALZN Omega Ratio Rank: 55
Omega Ratio Rank
ALZN Calmar Ratio Rank: 66
Calmar Ratio Rank
ALZN Martin Ratio Rank: 77
Martin Ratio Rank

MLGO
MLGO Risk / Return Rank: 88
Overall Rank
MLGO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
MLGO Sortino Ratio Rank: 44
Sortino Ratio Rank
MLGO Omega Ratio Rank: 66
Omega Ratio Rank
MLGO Calmar Ratio Rank: 44
Calmar Ratio Rank
MLGO Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALZN vs. MLGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alzamend Neuro, Inc. (ALZN) and MicroAlgo Inc. (MLGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ALZNMLGODifference
Sharpe ratioReturn per unit of total volatility

-0.16

Sortino ratioReturn per unit of downside risk

+0.19

Omega ratioGain probability vs. loss probability

0.80

0.81

-0.01

Calmar ratioReturn relative to maximum drawdown

-0.89

-0.95

+0.05

Martin ratioReturn relative to average drawdown

-1.44

-1.10

-0.33

ALZN vs. MLGO - Sharpe Ratio Comparison

The current ALZN Sharpe Ratio is -0.93, which is comparable to the MLGO Sharpe Ratio of -0.77. The chart below compares the historical Sharpe Ratios of ALZN and MLGO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ALZNMLGODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.93

-0.77

-0.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.67

-0.18

-0.49

Drawdowns

ALZN vs. MLGO - Drawdown Comparison

The maximum ALZN drawdown since its inception was -100.00%, roughly equal to the maximum MLGO drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for ALZN and MLGO.


Loading charts...

Drawdown Indicators


ALZNMLGODifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-100.00%

0.00%

Max Drawdown (1Y)

Largest decline over 1 year

-78.40%

-91.65%

+13.25%

Max Drawdown (3Y)

Largest decline over 3 years

-99.91%

-99.99%

+0.08%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

Current Drawdown

Current decline from peak

-99.99%

-99.99%

0.00%

Average Drawdown

Average peak-to-trough decline

-94.67%

-63.14%

-31.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

48.72%

79.06%

-30.34%

Volatility

ALZN vs. MLGO - Volatility Comparison

The current volatility for Alzamend Neuro, Inc. (ALZN) is 20.35%, while MicroAlgo Inc. (MLGO) has a volatility of 47.32%. This indicates that ALZN experiences smaller price fluctuations and is considered to be less risky than MLGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALZNMLGODifference

Volatility (1M)

Calculated over the trailing 1-month period

20.35%

47.32%

-26.97%

Volatility (6M)

Calculated over the trailing 6-month period

65.62%

75.14%

-9.52%

Volatility (1Y)

Calculated over the trailing 1-year period

76.26%

112.66%

-36.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

128.28%

481.13%

-352.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

128.28%

474.38%

-346.10%

Dividends

ALZN vs. MLGO - Dividend Comparison

Neither ALZN nor MLGO has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ALZN vs. MLGO - Financials Comparison

This section allows you to compare key financial metrics between Alzamend Neuro, Inc. and MicroAlgo Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
13.13M
(ALZN) Total Revenue
(MLGO) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ALZN and MLGO have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MLGO has higher volatility (47.32%) compared to ALZN (20.35%). In terms of maximum drawdown, ALZN dropped -100.00% vs MLGO's -100.00%.

MLGO currently has the higher Sharpe Ratio (-0.77 vs -0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALZN and MLGO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer